Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023

We report two extensively drug-resistant (XDR) Neisseria gonorrhoeae (NG) isolates combining high-level resistance to azithromycin and resistance to ceftriaxone, obtained in France from two heterosexual patients, one of whom returned from Cambodia. Whole genome sequencing identified MLST ST16406, the mosaic penA-60.001 which caused ceftriaxone resistance in the internationally spreading FC428 clone, and the A2059G mutation in the 23S rRNA gene. The NG isolates F93 and F94 were related to XDR isolates detected in Austria and the United Kingdom in 2022.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:28

Enthalten in:

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin - 28(2023), 37 vom: 22. Sept.

Sprache:

Englisch

Beteiligte Personen:

Maubaret, Clara [VerfasserIn]
Caméléna, François [VerfasserIn]
Mrimèche, Manel [VerfasserIn]
Braille, Aymeric [VerfasserIn]
Liberge, Mathilde [VerfasserIn]
Mainardis, Mary [VerfasserIn]
Guillaume, Clémence [VerfasserIn]
Noel, Franck [VerfasserIn]
Bébéar, Cécile [VerfasserIn]
Molina, Jean-Michel [VerfasserIn]
Lot, Florence [VerfasserIn]
Chazelle, Emilie [VerfasserIn]
Berçot, Béatrice [VerfasserIn]

Links:

Volltext

Themen:

75J73V1629
83905-01-5
Azithromycin
Bacterial infections
Case Reports
Ceftriaxone
Gonorrhoea
Journal Article
Laboratory
Laboratory surveillance
Molecular methods
Multidrug resistance
Sexually transmitted infections
Typing
XDR, gonorrhea, penA-60.001, A2059G mutation, France

Anmerkungen:

Date Completed 31.10.2023

Date Revised 01.12.2023

published: Print

Citation Status MEDLINE

doi:

10.2807/1560-7917.ES.2023.28.37.2300456

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM362052123